Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
55 studies found for:    ovarian,cancer,detection | Open Studies
Show Display Options
Rank Status Study
21 Not yet recruiting Value of MRI in the Characterization of Ovarian Masses Unable to Classify With Ultrasound Using the International Ovarian Tumor Analysis (IOTA) Simple Rules
Condition: Patients With a Sonographically Unclassifiable Adnexal Mass Using the IOTA Simple Rules
Intervention: Other: Diffusion/Perfusion-weighted Magnetic Resonance Imaging
22 Recruiting Impact of Gated PET/CT in the Diagnosis of Advanced Ovarian Cancer
Conditions: Ovarian Cancer Stage III;   Ovarian Cancer Stage IV
Intervention: Device: PET/CT
23 Recruiting Lavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial Carcinoma
Conditions: Ovarian Epithelial Cancer;   Carcinoma in Situ;   Ovarian Cancer
Intervention: Procedure: Lavage of the Cavum uteri and proximal Fallopian tubes, performed in the luteal phase of the female cycle
24 Recruiting Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease
Conditions: Mutation;   Neoplasms
Intervention: Genetic: ctDNA Analysis for the Detection of Genetic Mutations
25 Recruiting Evaluation of Multiple Biomarkers to Estimate Risk of Ovarian Cancer in Patients With a Pelvic Mass.
Condition: Ovarian Neoplasms
Interventions: Procedure: Pelvic imaging;   Procedure: Blood draw;   Procedure: laparotomy or laparoscopy
26 Unknown  Sentinel Node in Ovarian Cancer
Conditions: Ovarian Cancer;   Sentinel Node
Intervention: Procedure: blue dye and radioactive tracer
27 Recruiting Evaluation of Multiple Protein and Molecular Biomarkers to Estimate Risk of Cancer in Gynecology Patients Presenting With a Pelvic Mass.
Condition: Ovarian Neoplasms
Interventions: Procedure: Pelvic imaging;   Procedure: Blood draw;   Procedure: Imaging guided biopsy, surgical biopsy or surgical excision
28 Recruiting Olaparib and Cediranib Maleate in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Conditions: BRCA1 Gene Mutation;   BRCA2 Gene Mutation;   Fallopian Tube Endometrioid Adenocarcinoma;   Fallopian Tube Serous Adenocarcinoma;   High Grade Ovarian Serous Adenocarcinoma;   Ovarian Endometrioid Tumor;   Primary Peritoneal Serous Adenocarcinoma;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma
Interventions: Drug: Cediranib Maleate;   Other: Laboratory Biomarker Analysis;   Drug: Olaparib;   Other: Pharmacological Study
29 Not yet recruiting Individual Survivorship Program for Ovarian Cancer Patients Based on PROM's and Shared Decision Making
Conditions: Ovarian Cancer;   PROM;   Quality of Life
30 Recruiting Hula, a Physical Activity Intervention for Female-Cancer Survivors
Conditions: Physical Activity;   Breast Cancer;   Cervical Cancer;   Ovarian Cancer;   Endometrial Cancer
Intervention: Behavioral: Hula
31 Unknown  Mesothelin as a New Tumor Marker for Ovarian Cancer
Condition: Ovarian Cancer
32 Recruiting Fermented Wheat Germ Extract in Women With Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Fermented Wheat Germ Extract (FWGE);   Drug: Placebo;   Procedure: Planned Surgery;   Other: Quality of Life (QoL) Surveys: FACT-O
33 Not yet recruiting DNA Single Nucleotide Polymorphisms as Predictors of Toxicity
Conditions: Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Peritoneal Neoplasms
34 Unknown  Blood Test for Ovarian Cancer Associated Auto Antibodies
Condition: Ovarian Cancer
35 Recruiting Pilot Study With the Aim to Quantify a Stress Protein in the Blood and in the Urine for the Monitoring and Early Diagnosis of Malignant Solid Tumors
Condition: Cancer
Interventions: Other: blood samples;   Other: Urine samples
36 Unknown  Contrast-Enhanced Ultrasound Ability in the Characterization of Ovarian Masses
Condition: Ovarian Tumor
Intervention: Procedure: Contrast-enhanced ultrasound
37 Not yet recruiting MED-C Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Conditions: Neoplasms;   Lung Neoplasms;   Colon Neoplasms;   Breast Neoplasms;   Pancreatic Neoplasms;   Prostate Neoplasms;   Kidney Neoplasms;   Liver Neoplasms;   Rectal Neoplasms;   Hematologic Neoplasms;   Multiple Myeloma;   Myelodysplastic Syndromes;   Ovarian Neoplasms;   Bladder Neoplasms;   Testicular Neoplasms;   Endometrial Neoplasms;   Brain Neoplasms;   Biliary Tract Neoplasms;   Head and Neck Neoplasms;   Uterine Cervical Neoplasms;   Skin Neoplasms;   Melanoma;   Gastric Neoplasms;   Anal Neoplasms;   Sarcoma
Intervention: Other: Provider determined
38 Recruiting Trial on Radical Upfront Surgery in Advanced Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Procedure: PDS;   Drug: 6 cycles of standard chemotherapy;   Drug: 3 cycles of standard NACT;   Procedure: IDS;   Drug: 3 cycles of standard chemotherapy
39 Recruiting FSH-R : Diagnostic Application for Localized Tumors in Cancerology
Condition: Cancer
Intervention: Procedure: blood sample for FSHR analysis
40 Not yet recruiting Prospective Identification and Validation of "BRCANess" Profile in Ovarian Epithelial Cancer
Condition: Ovarian Neoplasms

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-55) Show next page of results    Last Page
Indicates status has not been verified in more than two years